{
  "ticker": "IVX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02961307",
  "id": "02961307",
  "pages": 7,
  "price_sensitive": false,
  "date": "20250624",
  "time": "0859",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250624/pdf/06l1b5n65n6qk1.pdf",
  "summary": "### **Capital Raising Announcement Summary**  \n\n- **Structure**: Non-renounceable entitlement offer + piggyback loyalty options  \n- **Total proposed issuance**:  \n  - **New shares (entitlement offer)**: 65,748,609 at **AUD 0.015/share**  \n  - **Loyalty options**: Exercisable at **AUD 0.14** (expiry 30/6/2027)  \n  - **Piggyback options**: 1 free option per 2 loyalty options exercised by 31/12/2025 (exercise price **AUD 0.21**; max 32.9m issuable)  \n- **Use of funds**: R&D (cancer trials), raising costs, working capital  \n- **Underwriting**: Fully underwritten by Blue Ocean Equities (fee: 3.5% management + 2.5% selling)  \n- **Sub-underwriting**: AUD 150k by Polar Ventures (related party)  \n- **Key dates**:  \n  - Ex-date: **25/6/2025**  \n  - Record date: **26/6/2025**  \n  - Offer close: **10/7/2025**  \n  - Trading starts (deferred): **11/7/2025**  \n\n*No other material information identified.*",
  "usage": {
    "prompt_tokens": 2803,
    "completion_tokens": 284,
    "total_tokens": 3087,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-23T23:16:10.694101"
}